XNAS · Healthcare · Medical Devices
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | Q1 2026 | -0.14 | -0.08 | +42.86% | $39,000 | ✅ Beat | -0.02% | +10.81% | — |
| 2026-03-23 | Q4 2025 | -0.24 | -0.26 | -8.33% | $75,000 | ❌ Miss | +0.04% | -14.30% | -8.25% |
| 2025-11-10 |
| Q3 2025 |
| -0.28 |
| -0.35 |
| -25.00% |
| $42,000 |
| ❌ Miss |
| — |
| — |
| — |
| 2025-07-31 | Q2 2025 | -0.29 | -0.32 | -10.34% | $78,000 | ❌ Miss | -8.16% | +0.68% | -15.76% |
| 2025-03-31 | Q4 2024 | -0.31 | -0.46 | -48.39% | $42,000 | ❌ Miss | +0.77% | -2.31% | +9.23% |
| 2024-11-14 | Q3 2024 | -0.27 | -0.37 | -37.04% | $56,000 | ❌ Miss | +0.47% | +3.29% | -17.37% |
| 2024-08-12 | Q2 2024 | -0.25 | -0.27 | -8.00% | $68,000 | ❌ Miss | -4.44% | +3.70% | +17.78% |
| 2024-05-15 | Q1 2024 | -0.26 | -0.32 | -23.08% | $59,000 | ❌ Miss | +1.00% | +1.34% | -12.37% |
Showing last 8 quarters.